What is the debt of Kobayashi Pharmaceutical Co this year?
Kobayashi Pharmaceutical Co has a debt level of -70,549 JPY this year.
Kobayashi Pharmaceutical Co Debt 2024
Kobayashi Pharmaceutical Co Debt
-70,549 JPY
Ticker
4967.T
ISIN
JP3301100008
WKN
920477
In 2024, Kobayashi Pharmaceutical Co's total debt was -70,549 JPY, a -26.08% change from the -95,441 JPY total debt recorded in the previous year.
Kobayashi Pharmaceutical Co Aktienanalyse
What does Kobayashi Pharmaceutical Co do?
Kobayashi Pharmaceutical Co Ltd is a Japanese company that specializes in the production of health products. Kobayashi Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Kobayashi Pharmaceutical Co's Debt Structure
Kobayashi Pharmaceutical Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Kobayashi Pharmaceutical Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Kobayashi Pharmaceutical Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Kobayashi Pharmaceutical Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Kobayashi Pharmaceutical Co stock
What was the debt of Kobayashi Pharmaceutical Co compared to the previous year?
The debt of Kobayashi Pharmaceutical Co has increased by -26.08% compared to the previous year dropped.
What are the consequences of high debt for investors in Kobayashi Pharmaceutical Co?
High debt can pose a risk for investors of Kobayashi Pharmaceutical Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Kobayashi Pharmaceutical Co?
Low debt means that Kobayashi Pharmaceutical Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Kobayashi Pharmaceutical Co affect the company?
An increase in debt of Kobayashi Pharmaceutical Co can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Kobayashi Pharmaceutical Co affect the company?
A reduction in debt of Kobayashi Pharmaceutical Co can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Kobayashi Pharmaceutical Co?
Some factors that can influence the debt of Kobayashi Pharmaceutical Co include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Kobayashi Pharmaceutical Co so important for investors?
The debts of Kobayashi Pharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Kobayashi Pharmaceutical Co take to change the debt?
To change the debt, Kobayashi Pharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Kobayashi Pharmaceutical Co pay?
Over the past 12 months, Kobayashi Pharmaceutical Co paid a dividend of 101 JPY . This corresponds to a dividend yield of about 1.84 %. For the coming 12 months, Kobayashi Pharmaceutical Co is expected to pay a dividend of 107.77 JPY.
What is the dividend yield of Kobayashi Pharmaceutical Co?
The current dividend yield of Kobayashi Pharmaceutical Co is 1.84 %.
When does Kobayashi Pharmaceutical Co pay dividends?
Kobayashi Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, January, July, January.
How secure is the dividend of Kobayashi Pharmaceutical Co?
Kobayashi Pharmaceutical Co paid dividends every year for the past 23 years.
What is the dividend of Kobayashi Pharmaceutical Co?
For the upcoming 12 months, dividends amounting to 107.77 JPY are expected. This corresponds to a dividend yield of 1.96 %.
In which sector is Kobayashi Pharmaceutical Co located?
Kobayashi Pharmaceutical Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Kobayashi Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Kobayashi Pharmaceutical Co from 3/1/2025 amounting to 59 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.
When did Kobayashi Pharmaceutical Co pay the last dividend?
The last dividend was paid out on 3/1/2025.
What was the dividend of Kobayashi Pharmaceutical Co in the year 2023?
In the year 2023, Kobayashi Pharmaceutical Co distributed 90 JPY as dividends.
In which currency does Kobayashi Pharmaceutical Co pay out the dividend?
The dividends of Kobayashi Pharmaceutical Co are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Kobayashi Pharmaceutical Co
Our stock analysis for Kobayashi Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kobayashi Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Kobayashi Pharmaceutical Co Revenue
- Kobayashi Pharmaceutical Co Net Income
- Kobayashi Pharmaceutical Co P/E
- Kobayashi Pharmaceutical Co P/S
- Kobayashi Pharmaceutical Co EBIT
- Kobayashi Pharmaceutical Co Dividend
- Kobayashi Pharmaceutical Co Stocks
- Kobayashi Pharmaceutical Co Market capitalization
- Kobayashi Pharmaceutical Co Debt
- Kobayashi Pharmaceutical Co Liabilities
- Kobayashi Pharmaceutical Co Equity
- Kobayashi Pharmaceutical Co AAQS
- Kobayashi Pharmaceutical Co Employees
- Kobayashi Pharmaceutical Co ROE
- Kobayashi Pharmaceutical Co ROA
- Kobayashi Pharmaceutical Co ROCE
